Gilead Sciences Inc said an unauthorized network of drug distributors and suppliers sold pharmacies more than $250 million of counterfeit versions of its HIV treatments over the last two years, endangering patients. The drugmaker said it found 85,247 bottles that had been tampered with or faked, including versions of its Biktarvy and Descovy treatments. In a separate statement on January 19, Gilead said it has seized the bottles of Gilead-labeled medication from 17 locations in nine states as part of its investigation.
展开▼
